PCL-5 (PTSD Checklist for DSM-5): 20-Item Scoring, Symptom Clusters, CAPS-5, and Cutoffs

The PTSD Checklist for DSM-5 (PCL-5)—developed by Frank W. Weathers, Brett T. Litz, Terence M. Keane, Patrick A. Palmieri, Brian P. Marx, and Paula P. Schnurr (2013) at the U.S. Department of Veterans Affairs National Center for PTSD—is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of Posttraumatic Stress Disorder (PTSD). Used across VA/DoD clinical care, epidemiological cohorts, and psychiatry clinical trials, the PCL-5 quantifies symptom severity over the past month (or past week in repeated longitudinal tracking), screens for provisional PTSD diagnosis, and tracks treatment response alongside the gold-standard clinician interview, the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5).

Three PCL-5 Administration Formats

The VA National Center for PTSD distributes the PCL-5 in three standardized formats depending on how DSM-5 Criterion A (exposure to actual or threatened death, serious injury, or sexual violence) is evaluated:

1. PCL-5 without Criterion A: Contains only the 20 symptom items, used when index trauma exposure has already been documented through another clinical assessment.
2. PCL-5 with Criterion A: Includes a brief introductory trauma exposure page where the respondent identifies their worst stressful experience (index event), when it occurred, and how it was experienced (directly, witnessed, learned about a close family member/friend, or repeated occupational exposure) before answering the 20 symptom items anchored to that event.
3. PCL-5 with the Life Events Checklist for DSM-5 (LEC-5) and Extended Criterion A: Pairs the 17-item LEC-5 trauma inventory with an extended Criterion A assessment prior to the 20 PCL-5 items.

How Is the 20-Item Weathers PTSD Checklist for DSM-5 (PCL-5, 0–80) Scored Across DSM-5 Clusters B, C, D, and E?

Each of the 20 items on the PCL-5 is rated on a 5-point Likert scale from 0 to 4 reflecting how much the respondent has been bothered by that problem in the past month:

• 0 = Not at all
• 1 = A little bit
• 2 = Moderately
• 3 = Quite a bit
• 4 = Extremely

Notice that unlike the legacy DSM-IV PCL (which scored 17 items from 1–5 for a 17–85 range), the DSM-5 PCL-5 uses 0-based scoring (0–4) across 20 items, yielding a total severity score from 0 to 80. Scores from the legacy PCL and the PCL-5 are not directly interchangeable. The 20 items map 1-to-1 onto the four DSM-5 PTSD symptom clusters:

DSM-5 Symptom Cluster	PCL-5 Item Numbers	Subscale Score Range	Symptoms Assessed
Cluster B: Intrusion (Re-experiencing)	Items 1–5 (5 items)	0–20	Intrusive memories (1), distressing dreams (2), dissociative flashbacks (3), psychological cue distress (4), physiological cue reactivity (5)
Cluster C: Persistent Avoidance	Items 6–7 (2 items)	0–8	Avoidance of internal trauma memories/thoughts/feelings (6), avoidance of external reminders/people/places (7)
Cluster D: Negative Alterations in Cognitions and Mood	Items 8–14 (7 items)	0–28	Trauma amnesia (8), negative beliefs (9), distorted blame (10), persistent negative emotions (11), diminished interest/anhedonia (12), detachment/estrangement (13), inability to experience positive emotions (14)
Cluster E: Marked Alterations in Arousal and Reactivity	Items 15–20 (6 items)	0–24	Irritable/angry outbursts (15), reckless/self-destructive behavior (16), hypervigilance (17), exaggerated startle response (18), concentration difficulties (19), sleep disturbance (20)

What Is the Difference Between the PCL-5 Provisional Cutoff (31–33), DSM-5 Symptom-Cluster Rule, and Reliable/Clinically Significant Change (5 vs. 10 Points)?

The VA National Center for PTSD (Weathers et al., 2013; Bovin et al., 2016) defines two complementary methods for determining a provisional PTSD diagnosis from the PCL-5 (note that a definitive diagnosis always requires a structured clinical interview):

1. Total Severity Score Cutoff (31–33): A total score of 31 to 33 or higher (out of 80) is the validated psychometric cutoff for probable PTSD across veteran and civilian validation cohorts (Blevins et al., 2015; Bovin et al., 2016). Clinical settings prioritizing sensitivity use ≥31, while research protocols prioritizing specificity against the CAPS-5 frequently use ≥33.
2. DSM-5 Symptom-Cluster Endorsement Rule: Treats any item rated ≥2 (“Moderately” or higher) as an endorsed symptom, then applies the DSM-5 diagnostic algorithm:
   • At least 1 Cluster B item (Items 1–5 rated ≥2), AND
   • At least 1 Cluster C item (Items 6–7 rated ≥2), AND
   • At least 2 Cluster D items (Items 8–14 rated ≥2), AND
   • At least 2 Cluster E items (Items 15–20 rated ≥2).

For longitudinal treatment monitoring in psychotherapy (such as Prolonged Exposure or Cognitive Processing Therapy) and pharmacotherapy trials, the VA National Center for PTSD specifies two change benchmarks:

• Reliable Change (5 to 10 points): A minimum change of 5 points is the threshold for determining that an individual’s symptom change is not due to random measurement error (reliable change index).
• Clinically Significant / Meaningful Change (10 to 20 points): A reduction of 10 to 20 points represents a clinically meaningful treatment response.

How Does the Self-Report PCL-5 Pair with the Gold-Standard 30-Item CAPS-5, PC-PTSD-5, and IES-R in Clinical Trials?

In trauma research and regulatory clinical trials (implementing ePRO in clinical trials and electronic clinical outcome assessment workflows), the PCL-5 is embedded within a tiered assessment hierarchy alongside the PC-PTSD-5, the CAPS-5, and legacy instruments such as the Impact of Event Scale–Revised (IES-R) and Brief Resilience Scale (BRS):

• PC-PTSD-5 (Primary Care PTSD Screen for DSM-5; Prins et al., 2016): A 5-item binary (Yes/No, range 0–5) rapid triage screen used in primary care and mental health intake forms. Patients scoring ≥3 (or ≥4 when maximizing specificity) are referred to complete the 20-item PCL-5 or a structured clinical interview.
• CAPS-5 (Clinician-Administered PTSD Scale for DSM-5; Weathers et al., 2018): The 30-item structured clinical interview (ClinRO) that serves as the gold-standard primary endpoint in VA/DoD and FDA registration trials for PTSD. Taking 45–60 minutes to administer, the CAPS-5 evaluates the 20 core DSM-5 symptoms (producing a 0–80 total severity score where trained clinicians combine symptom frequency and intensity into a single 0–4 severity rating: 0 = Absent, 1 = Mild/subthreshold, 2 = Moderate/threshold, 3 = Severe/markedly elevated, 4 = Extreme/incapacitating), plus 10 additional items covering Criterion A, onset, duration (Criterion F), subjective distress/functional impairment (Criterion G), global validity/severity, and the dissociative subtype (depersonalization and derealization).
• IES-R (Impact of Event Scale–Revised; Weiss & Marmar, 1997): A 22-item self-report measure (0–4 per item, total 0–88) originally built around DSM-IV Intrusion (8 items), Avoidance (8 items), and Hyperarousal (6 items) subscales over a 7-day window. While still used in acute critical-illness and disaster cohorts for historical continuity, the IES-R does not cover DSM-5 Cluster D (negative cognitions and mood), making the PCL-5 the standard DSM-5/DSM-5-TR self-report instrument.

Frequently Asked Questions

How is the 20-item Weathers PTSD Checklist for DSM-5 (PCL-5, 0–80) scored across DSM-5 Clusters B, C, D, and E?

Each of the 20 PCL-5 items is scored from 0 (“Not at all”) to 4 (“Extremely”), summing to a 0–80 total severity score. Subscale scores are summed across Items 1–5 for Cluster B Intrusion (0–20), Items 6–7 for Cluster C Avoidance (0–8), Items 8–14 for Cluster D Negative Cognitions and Mood (0–28), and Items 15–20 for Cluster E Arousal and Reactivity (0–24).

What is the difference between the PCL-5 provisional cutoff (31–33), DSM-5 symptom-cluster rule, and reliable/clinically significant change (5 vs. 10 points)?

A total PCL-5 score of 31–33 or higher indicates probable PTSD by severity, whereas the DSM-5 cluster rule requires endorsing at least 1 Cluster B item, 1 Cluster C item, 2 Cluster D items, and 2 Cluster E items at a rating of ≥2 (“Moderately”). Over time, a 5–10 point decrease represents reliable change beyond measurement error, and a 10–20 point decrease represents clinically meaningful improvement.

How does the self-report PCL-5 pair with the gold-standard 30-item Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) in VA/DoD and FDA trials?

In PTSD clinical trials, the 30-item clinician-rated CAPS-5 (0–80 severity across the 20 core symptoms, combining frequency and intensity into 0–4 ratings plus duration, impairment, and dissociative subtype items) serves as the primary diagnostic and efficacy endpoint at baseline and primary endpoint visits, while the 20-item self-report PCL-5 (0–80) is collected weekly or biweekly to track intermediate symptom trajectories.